|
Market Closed -
Deutsche Boerse AG
02:04:53 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 14.46 EUR | +1.26% |
|
+2.84% | +175.69% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 681.13 | +16.67% | 23 | ||||||
| 247.11 | +18.87% | 21 | ||||||
| 275.17 | +5.13% | 18 | ||||||
| 432.16 | +17.84% | 28 | ||||||
| 266,031.64 | +39.5% | 23 | ||||||
| 581.83 | -3.13% | 12 | ||||||
| 271.49 | +27.58% | 20 | ||||||
| 72.53 | +0.23% | 14 | ||||||
| 281 | -3.6% | 14 | ||||||
| 185.56 | +9.14% | 16 | ||||||
| 63.36 | -1.07% | 14 | ||||||
| 70.73 | -2.24% | 11 | ||||||
| 49.79 | +13.73% | 11 | ||||||
| 138.97 | +42.68% | 6 | ||||||
| 134.85 | -0.09% | 11 | ||||||
| 88 | +44.14% | 22 | ||||||
| 132.5 | +12.15% | 22 | ||||||
| 3.72 | -16.71% | 7 | ||||||
| 638.68 | +85.26% | 19 | ||||||
| Average | 14,230.54 | +16.11% | 16 | ||||||
| Weighted average by Cap. | 23,436.32 | +16.29% | 19 |
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Sector GENFIT
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
